198 related articles for article (PubMed ID: 37254438)
21. Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors.
Salem MA; Ragab A; El-Khalafawy A; Makhlouf AH; Askar AA; Ammar YA
Bioorg Chem; 2020 Mar; 96():103619. PubMed ID: 32036161
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL
Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549
[TBL] [Abstract][Full Text] [Related]
23. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase.
Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH
Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364
[TBL] [Abstract][Full Text] [Related]
24. Development and radiosterilization of new hydrazono-quinoline hybrids as DNA gyrase and topoisomerase IV inhibitors: Antimicrobial and hemolytic activities against uropathogenic isolates with molecular docking study.
Ammar YA; Micky JA; Aboul-Magd DS; Abd El-Hafez SMA; Hessein SA; Ali AM; Ragab A
Chem Biol Drug Des; 2023 Feb; 101(2):245-270. PubMed ID: 36305722
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, antimicrobial screening and molecular modeling of novel 6,7 dimethylquinoxalin-2(1H)-one and thiazole derivatives targeting DNA gyrase enzyme.
Alqurashi RM; Farghaly TA; Sabour R; Shaabana MR
Bioorg Chem; 2023 May; 134():106433. PubMed ID: 36842318
[TBL] [Abstract][Full Text] [Related]
26. Benzothiazole Clubbed Imidazolone Derivatives: Synthesis, Molecular Docking, DFT Studies, and Antimicrobial Studies.
Desai N; Maheta A; Jethawa A; Ahmad I; Patel H; Dave B
Curr Comput Aided Drug Des; 2023; 19(2):123-136. PubMed ID: 36411562
[TBL] [Abstract][Full Text] [Related]
27. New Benzopyrrole Derivatives: Synthesis and Appraisal of Their Potential as Antimicrobial Agents.
Nandurkar D; Menghani S; Danao K; Rokde V; Rarokar N; Khedekar P; Mana S
Chem Biodivers; 2023 Jul; 20(7):e202300394. PubMed ID: 37300516
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
29. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D
Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868
[TBL] [Abstract][Full Text] [Related]
30. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
Metwally NH; Abdallah SO; Mohsen MMA
Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
[TBL] [Abstract][Full Text] [Related]
31. Novel N-α-amino acid spacer-conjugated phthalimide-triazine derivatives: synthesis, antimicrobial and molecular docking studies.
Asadi P; Khodamoradi E; Khodarahmi G; Jahanian-Najafabadi A; Marvi H; Dehghan Khalili S
Amino Acids; 2023 Mar; 55(3):337-348. PubMed ID: 36617370
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives.
El-Shershaby MH; El-Gamal KM; Bayoumi AH; El-Adl K; Ahmed HEA; Abulkhair HS
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000277. PubMed ID: 33078877
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, Identification, Computer-Aided Docking Studies, and ADMET Prediction of Novel Benzimidazo-1,2,3-triazole Based Molecules as Potential Antimicrobial Agents.
Rashdan HRM; Abdelmonsef AH; Abou-Krisha MM; Yousef TA
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885701
[TBL] [Abstract][Full Text] [Related]
34. New thiazolyl-isoxazole derivatives as potential anti-infective agents: design, synthesis,
Bhoye MR; Shinde A; Shaikh ALN; Shisode V; Chavan A; Maliwal D; Pissurlenkar RRS; Mhaske PC
J Biomol Struct Dyn; 2024 Jan; ():1-15. PubMed ID: 38258445
[TBL] [Abstract][Full Text] [Related]
35. Atomistic simulation on flavonoids derivatives as potential inhibitors of bacterial gyrase of
Ramachandran B; Srinivasadesikan V; Chou TM; Jeyakanthan J; Lee SL
J Biomol Struct Dyn; 2022 Jul; 40(10):4314-4327. PubMed ID: 33308046
[TBL] [Abstract][Full Text] [Related]
36. Anti-tubercular Modelling via QSAR Approach, In Silico Design and Virtual Docking Screening of Designed Hypothetical Inhibitors Against DNA gyrase Protein.
Adeniji SE
Curr Comput Aided Drug Des; 2021; 17(6):739-758. PubMed ID: 32586260
[TBL] [Abstract][Full Text] [Related]
37. In vitro antimicrobial evaluation and in silico studies of coumarin derivatives tagged with pyrano-pyridine and pyrano-pyrimidine moieties as DNA gyrase inhibitors.
Fayed EA; Nosseir ES; Atef A; El-Kalyoubi SA
Mol Divers; 2022 Feb; 26(1):341-363. PubMed ID: 33895960
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and
Kumar S; Shah P; Tripathi SK; Khan SI; Singh IP
Med Chem; 2022; 18(9):949-969. PubMed ID: 35240963
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, In silico Molecular Docking and Pharmacokinetic Studies, In vitro Antimycobacterial and Antimicrobial Studies of New Imidozolones Clubbed with Thiazolidinedione.
Khan IH; Patel NB; Patel VM
Curr Comput Aided Drug Des; 2018; 14(4):269-283. PubMed ID: 29766819
[TBL] [Abstract][Full Text] [Related]
40. Design, molecular docking study of synthesised
Mahapatra M; Paidesetty SK; Bishoyi AK; Padhy RN
Nat Prod Res; 2022 Nov; 36(21):5575-5583. PubMed ID: 35105197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
